UBS raises target for Givaudan stock from CHF 3,270 to CHF 3,960

Published on 10/21/2026 at 10:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS raised its target to CHF 3,960 on October 15, 2026. Givaudan stock costs EUR 4,269.50 on October 21, 2026 and reported nine-month sales reached CHF 5,891 million.

Analyst target and sales growth

UBS lifted its Givaudan target from CHF 3,270 to CHF 3,960 on October 15, 2026.
Givaudan reported CHF 5,891 million in nine-month sales for 2026, up 5.2 percent like for like.
Givaudan stock was trading at EUR 4,269.50 at 10:03 a.m. CEST at Lang & Schwarz on October 21, 2026.

A high-contrast black and white documentary photograph of an aroma evaluation session. A row of tasters sit along a long table, each holding white scent strips to their noses. Rows of small unlabelled vials are arranged before them. Harsh directional flas — Givaudan CH0010645932 Schwarz-Weiss-Reportage zeigt Aromen-Verkostung mit Duftstreifen, Probengläsern und strengem dokumentarischen Stil, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was trading at EUR 4,269.50 at Lang & Schwarz on October 21, 2026 at 10:03 a.m. CEST. According to finanzen.ch, UBS raised its Givaudan target from CHF 3,270 to CHF 3,960 on October 15, 2026 while keeping a Neutral rating.

Sales beat expectations in September

Givaudan reported sales of CHF 5,891 million for the first nine months of 2026, up 5.2 percent on a like-for-like basis and 2.6 percent in Swiss francs from the comparable period. The company also said it raised prices with customers to compensate for higher input costs, according to its Givaudan release dated October 13, 2026.

The third quarter supplied the strongest operating signal. Sales reached CHF 2,092 million, up 11.3 percent in reported terms and 8.6 percent like for like from the third quarter of 2025. Reuters reported that the like-for-like result exceeded the company-compiled consensus of 4.7 percent, while Fragrance and Beauty grew 13.5 percent against an expected 6.6 percent.

What does the target change mean?

UBS sees faster growth as increasingly reflected in the valuation. Its analyst Joshua Spector said the next quarter may not exceed expectations by the same margin, creating a counterweight to the sales momentum. JPMorgan took a more constructive view on October 13, 2026, raising its target from CHF 3,700 to CHF 4,100 and retaining Overweight, according to Ariva.

Three dated steps for Givaudan

On October 13, 2026, Givaudan reported CHF 5,891 million in nine-month sales. On October 13, 2026, JPMorgan lifted its target to CHF 4,100. On October 15, 2026, UBS lifted its target to CHF 3,960.

Dates for the next update

The next scheduled full-year results are due on January 27, 2027, according to the company release. Givaudan also lists an investor event in Zurich for October 29, 2026, on its investor relations page.

Stock price and valuation signals

Givaudan's two divisions are Fragrance and Beauty and Taste and Wellbeing. The company targets average like-for-like sales growth of 4 to 6 percent and adjusted free cash flow above 12 percent over its five-year strategic period. Its market capitalization was CHF 36.4 billion as of October 21, 2026.

Givaudan stock was trading at EUR 4,269.50 at Lang & Schwarz on October 21, 2026 at 10:03 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.

Givaudan stock facts

Company: Givaudan S.A.
ISIN: CH0010645932
Ticker: GIVN
Primary exchange: SIX
Price Lang & Schwarz (as of October 21, 2026, 10:03 a.m. CEST): EUR 4,269.50
Market capitalization: CHF 36.4 billion (as of October 21, 2026)
Sector / Industry: Basic Materials / Specialty Chemicals
Index membership: SMI
Next earnings date: January 27, 2027